Biodexa Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BDRX and other ETFs, options, and stocks.

About BDRX

Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. 

CEO
Stephen Anthony Stamp
CEOStephen Anthony Stamp
Employees
13
Employees13
Headquarters
Cardiff, Cardiff
HeadquartersCardiff, Cardiff
Founded
2000
Founded2000
Employees
13
Employees13

BDRX Key Statistics

Market cap
2.98M
Market cap2.98M
Price-Earnings ratio
-0.07
Price-Earnings ratio-0.07
Dividend yield
Dividend yield
Average volume
3.39M
Average volume3.39M
High today
$6.29
High today$6.29
Low today
$4.73
Low today$4.73
Open price
$5.82
Open price$5.82
Volume
457.48K
Volume457.48K
52 Week high
$92.00
52 Week high$92.00
52 Week low
$3.58
52 Week low$3.58

Stock Snapshot

The current Biodexa Pharmaceuticals(BDRX) stock price is $6.17, with a market capitalization of 2.98M. The stock trades at a price-to-earnings (P/E) ratio of -0.07.

During the trading session on 2025-12-15, Biodexa Pharmaceuticals(BDRX) shares reached a daily high of $6.29 and a low of $4.73. At a current price of $6.17, the stock is +30.4% higher than the low and still -1.9% under the high.

Trading volume for Biodexa Pharmaceuticals(BDRX) stock has reached 457.48K, versus its average volume of 3.39M.

The stock's 52-week range extends from a low of $3.58 to a high of $92.00.

The stock's 52-week range extends from a low of $3.58 to a high of $92.00.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.